CoChat

Bioprinting technologies for disease modeling

Memic, Adnan, Navaei, Ali, Mirani, Bahram, Cordova, Julio Alvin Vacacela, Aldhahri, Musab, Dolatshahi-Pirouz, Alireza, Akbari, Mohsen, Nikkhah, Mehdi · 2017 · Biotechnology Letters

The DOI matches its Crossref record; 71 of the 73 references it cites were found in a registry or an index.

Abstract

There is a great need for the development of biomimetic human tissue models that allow elucidation of the pathophysiological conditions involved in disease initiation and progression. Conventional two-dimensional (2D) in vitro assays and animal models have been unable to fully recapitulate the critical characteristics of human physiology. Alternatively, three-dimensional (3D) tissue models are often developed in a low-throughput manner and lack crucial native-like architecture. The recent emergence of bioprinting technologies has enabled creating 3D tissue models that address the critical challenges of conventional in vitro assays through the development of custom bioinks and patient derived cells coupled with well-defined arrangements of biomaterials. Here, we provide an overview on the technological aspects of 3D bioprinting technique and discuss how the development of bioprinted tissue models have propelled our understanding of diseases' characteristics (i.e. initiation and progression). The future perspectives on the use of bioprinted 3D tissue models for drug discovery application are also highlighted.

Overview

Integrity signals

Registry

Crossref · 10.1007/s10529-017-2360-z

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 71 references

Cited by

See all 73

Metadata

Authors
Memic, A., Navaei, A., Mirani, B., Cordova, J. A. V., Aldhahri, M., Dolatshahi-Pirouz, A., Akbari, M., & Nikkhah, M.
Affiliations
  • Arizona State University (US)
  • University of Victoria (CA)
  • Technical University of Denmark (DK)
  • King Abdulaziz University (SA)
Corresponding author
Nikkhah, Mehdi
Venue
Biotechnology Letters
Published
2017-05-26
Volume
39
Issue
9
Pages
1279-1290
ISSN
  • 0141-5492 (ISSN-L)
  • 1573-6776
OpenAlex
W2620300384
Cited by
73
References
73
Citations by year
2026: 2 · 2025: 8 · 2024: 6 · 2023: 10 · 2022: 13 · 2021: 8 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 1
FWCI
0.57
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Letters (publishedVersion)
  • PubMed (publishedVersion)
  • Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
Funders
  • National Science Foundation
  • Division of Chemical, Bioengineering, Environmental, and Transport Systems
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
bioprinting, disease modeling, 3D tissue models, bioinks, patient-derived cells, biomaterials, disease progression, drug discovery, in vitro disease model
MeSH terms
Humans, Models, Biological, Bioprinting, Printing, Three-Dimensional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioprinting technologies for disease modeling. https://app.cochat.ai/papers/10.1007/s10529-017-2360-z
The paper
Memic, A., Navaei, A., Mirani, B., Cordova, J. A. V., Aldhahri, M., Dolatshahi-Pirouz, A., Akbari, M., & Nikkhah, M. (2017). Bioprinting technologies for disease modeling. Biotechnology Letters. https://doi.org/10.1007/s10529-017-2360-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.